5114.0 Injection Drug Use and HIV: Innovative Approaches

Wednesday, October 29, 2008: 10:30 AM
This session will include state-of-the-art updates related to the delivery of HIV-related prevention and care services to injection drug users.
Session Objectives: Participants will be able to: 1. Describe epidemiologic trends in HIV among injection drug users. 2. Describe relations between sociocultural characteristics of injection drug using individuals and specific HIV-related risk behaviors. 3. Describe best practice standards for delivering care and prevention programs to injection drug users.

10:30 AM
Using HSV-2 and HCV co-infections to track sexual and injecting risk for HIV among injecting drug users
Don C. Des Jarlais, PhD, Kamyar Arasteh, PhD, Holly Hagan, PhD, Courtney McKnight, MPH and Samuel R. Friedman, PhD
10:45 AM
Differences in injection risk behaviors: A comparison between MSM IDU and non-MSM IDU
Karin Elizabeth Tobin, PhD, Errol Fields, MPH and Carl Latkin, PhD
11:00 AM
Spatial access to sterile syringes through the Expanded Syringe Access Demonstration Program (ESAP) in NYC: Description and relationship to need and local characteristics
Hannah LF Cooper, ScD, SM, Brian Bossak, PhD, MPH, Barbara Tempalski, MPH, PhD, Samuel R. Friedman, PhD and Don C. Des Jarlais, PhD
11:15 AM
Prevalence and correlates of HIV infection among young adult injection drug users (IDUs): The Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT) 2002-2004
Amanda J. Rondinelli, MPH, Steffanie A. Strathdee, PhD, Mary H. Latka, PhD, Lawrence J. Ouellet, PhD, Sharon M. Hudson, PhD, Holly Hagan, PhD and Richard S. Garfein, PhD, MPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: HIV/AIDS
Endorsed by: Public Health Education and Health Promotion, Socialist Caucus

CE Credits: CME, Health Education (CHES), Nursing

See more of: HIV/AIDS